Baxter International quarterly profit that tops estimates
Deerfield-based Baxter International Inc., the maker of hemophilia treatments that's splitting into two companies, reported first-quarter profit that topped analysts' estimates.
Profit excluding some items was $1 a share, Baxter said in a statement. Analysts had estimated 88 cents on average, according to data compiled by Bloomberg.
The company forecast second-quarter profit from continuing operations that trailed estimates.
Profit excluding certain items will be 92 cent to 96 cents a share. Analysts had forecast $1.02 on average.
Article Comments
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked.
If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.